Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
elementary friction phenomena and is focused on the usage of nanoparticle, lubricant additives, tribochemistry at the local scale to reduce friction and wear in the contact area. Scientific collaborations with
-
at the 'Group of Smart Nanoengineered Materials, Nanomechanics and Nanomagnetism -Gnm3' (https://jsort-icrea.uab.cat/) of the Universitat Autònoma de Barcelona (UAB). The position is in the framework
-
Development of the pre-clinical data package relating to the translation of various novel radiosensitising nanoparticles. The successful applicant will work as part of a team seeking to
-
nanotechnology into applications and therapeutics. The researcher will apply modern technologies for the chemical modification of RNA nanoparticles or mRNA for in vivo imaging and to deliver RNA in vivo
-
nanoparticles, cell survival and radioresistance. The MS-RADAM research programme combines state-of-the-artc omputational multiscale modelling (using DFT/TDDFT methods, collision theory, molecular dynamics
-
the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description 1) Preparation of multifunctional nanoparticles
-
. The project will thus contribute to more sustainable agriculture and to a better understanding of interactions between nanoparticles and the environment. Objectives. Indoor aquatic mesocosms will be
-
. Surface Chemistry & Biosensor Validation (30%) • Synthesize and functionalize gold nanoparticles (antibody grafting) by leveraging NanoBioSurf group expertise. • Characterize surfaces and nanostructures via
-
manufacturing procedures and the requirement for lymphodepleting chemotherapy, which together limit patient access. Here, we propose an in vivo engineering strategy based on targeted lipid nanoparticles (tLNPs
-
/UKCA), and standards for medical/assistive devices. Drug delivery systems – nanoelectronics, nanoparticles, and similar for therapeutic agent release (including closed loop/triggered release